Camsing Healthcare (BAC) Q1 2027 TU earnings summary

Executive summary

• Q1FY2027 revenue fell 30% YoY to S$871,000, while the net loss narrowed to S$299,000 from S$480,000, mainly on lower marketing costs and finance costs.

• Net liabilities widened to S$6.469m at 30 April 2026; going-concern status depends on controlling-shareholder support and sustained cost reductions and e-commerce growth.

Financial highlights

• Revenue was S$871,000, down 30% YoY; gross profit was S$477,000, down 26% YoY, and other income was S$15,000 versus S$61,000.

• Loss before tax and net loss were both S$299,000, versus S$480,000 in Q1FY2026; lower marketing and finance costs were partly offset by lower revenue and other income and higher administrative expenses.

• Marketing and distribution costs declined 52% to S$405,000; administrative and other operating expenses rose 16% to S$371,000, partly reflecting payroll reclassification.

• Cash and bank balances rose to S$178,000 from S$40,000 at 31 January 2026; operating cash outflow was S$280,000, versus S$200,000 a year earlier.

Outlook and guidance

• Cautious outlook amid uncertain global conditions and possible pressure on consumer sentiment; focus remains on cost discipline, margin preservation and modest, sustainable growth.

• Online sales showed improved growth; most customers were retained through redirection to other outlets or digital channels after retail closures.

• Discussions with potential strategic partners continue to explore new revenue streams; updates are expected if material developments arise.